Syon Capital LLC Tg Therapeutics, Inc. Transaction History
Syon Capital LLC
- $1.23 Trillion
- Q1 2025
A detailed history of Syon Capital LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Syon Capital LLC holds 12,735 shares of TGTX stock, worth $427,768. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,735
Previous 9,157
39.07%
Holding current value
$427,768
Previous $276 Million
82.18%
% of portfolio
0.04%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
407Shares Held
87.5MCall Options Held
2.33MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA15.6MShares$524 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$383 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$250 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$110 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$95.6 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.88B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...